Biomerica, Inc.

$BMRA is the best performer in the Prism MarketView Healthcare index as its up currently over 100%, after announcing their prostate screening test has received approval from the United Arab Emirates Ministry of Health and Prevention (MOHAP).

Share this article:

About the Author:

Biomerica, Inc.

Joey Ramson

PRISM Market View Alerts

Get your dose of PRISM Market
View news, right in your inbox

Mailchimp Signup